ARTG 482609

JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps

ARTG ID: 482609 · Life Healthcare Pty Ltd · Argon Medical Devices Inc · Class III · Started March 14, 2025

Good Name: Life Healthcare Pty Ltd - JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps

Device classification

Risk Class: Class III
Product Type: Single Device Product
ARTG Category: General

Registration information

ARTG ID: 482609
Start Date: March 14, 2025
Effective Date: March 25, 2025

Sponsor

Name: Life Healthcare Pty Ltd

Manufacturer

Name: Argon Medical Devices Inc
Country: United States of America
Address: 1445 Flat Creek Road, Athens, Texas, 75751

Intended purpose

The JAWZ Endomyocardial Biopsy Forceps are manually operated medical devices used to collect endomyocardial tissue samples from the inner wall of the heart for histopathological examination.

About this record

Access comprehensive regulatory information for JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 482609 and sponsored by Life Healthcare Pty Ltd, manufactured by Argon Medical Devices Inc in United States of America. The device registration started on March 14, 2025.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.